10x Genomics, Inc. Litigation Settlement Gain
10x Genomics, Inc. (TXG) reported Litigation Settlement Gain of $3.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:LitigationSettlementGain · last filed 2026-08-07
- 10x Genomics, Inc. litigation settlement gain for the quarter ending 2026-06-30 was $3.40M, a 91.65% decline year-over-year.
- 10x Genomics, Inc. litigation settlement gain for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- 10x Genomics, Inc. litigation settlement gain for the quarter ending 2025-12-31 was $0.00.
- 10x Genomics, Inc. litigation settlement gain for the quarter ending 2025-09-30 was $0.00.
- 10x Genomics, Inc. litigation settlement gain for fiscal 2025 was $49.90M.
- 10x Genomics, Inc. litigation settlement gain for fiscal 2024 was $0.00.
- 10x Genomics, Inc. litigation settlement gain for fiscal 2023 was $0.00.
| Period end | Litigation Settlement Gain 3 month | Litigation Settlement Gain 6 month | Litigation Settlement Gain 9 month | Litigation Settlement Gain 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.40M 10-Q · filed 2026-08-07 | $3.40M 10-Q · filed 2026-08-07 | $3.40M derived: sum of 3 quarters · filed 2026-08-07 | $3.40M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $0.00 derived: sum of 3 quarters · filed 2026-05-08 | $40.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $40.70M derived: sum of 3 quarters · filed 2026-08-07 | $49.90M 10-K · filed 2026-02-13 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 | $40.70M derived: sum of 2 quarters · filed 2026-08-07 | $49.90M 10-Q · filed 2025-11-07 | $49.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $40.70M 10-Q · filed 2026-08-07 | $49.90M 10-Q · filed 2026-08-07 | $49.90M derived: sum of 3 quarters · filed 2026-08-07 | $49.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $9.20M 10-Q · filed 2026-05-08 | $9.20M derived: sum of 2 quarters · filed 2026-05-08 | $9.20M derived: sum of 3 quarters · filed 2026-05-08 | $9.20M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $0.00 derived: sum of 3 quarters · filed 2026-02-13 | $0.00 10-K · filed 2026-02-13 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-13 |